You are here Home Guidance and resources Sponsors Novartis Pharmaceuticals Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Australian Public Assessment Report (AusPAR) (1) Date 2021 (1) Results for "[search-keyword]" Search Sponsor content1 result(s) found, displaying 1 to 1 AusPAR: Ofatumumab 24 June 2021 Australian Public Assessment Report (AusPAR) Australian Public Assessment Report for Ofatumumab
AusPAR: Ofatumumab 24 June 2021 Australian Public Assessment Report (AusPAR) Australian Public Assessment Report for Ofatumumab